Meropenem susceptibility breakpoint for Pseudomonas aeruginosa strains hyperproducing mexB mRNA
- 1 August 2005
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 11 (8), 662-669
- https://doi.org/10.1111/j.1469-0691.2005.01182.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Clinical Strains of Pseudomonas aeruginosa Overproducing MexAB-OprM and MexXY Efflux Pumps SimultaneouslyAntimicrobial Agents and Chemotherapy, 2004
- A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposesClinical Microbiology & Infection, 2003
- BSAC standardized disc susceptibility testing methodJournal of Antimicrobial Chemotherapy, 2001
- Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility testJournal of Antimicrobial Chemotherapy, 2001
- Characterization ofPseudomonas aeruginosaIsolates: Occurrence Rates, Antimicrobial Susceptibility Patterns, and Molecular Typing in the Global SENTRY Antimicrobial Surveillance Program, 1997–1999Clinical Infectious Diseases, 2001
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Of Pseudomonas, porins, pumps and carbapenemsJournal of Antimicrobial Chemotherapy, 2001
- Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa : Novel Agents for Combination TherapyAntimicrobial Agents and Chemotherapy, 2001
- Antibiotic disk diffusion testing revisited. Single strain regression analysisAPMIS, 1991
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977